Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia Response

被引：0
|
作者：
Kishi, Taro [1 ]
Ikuta, Toshikazu [2 ]
Matsuda, Yuki [1 ,3 ]
Iwata, Nakao [1 ]
机构：
[1] Fujita Hlth Univ, Dept Psychiat, Sch Med, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan
[2] Univ Mississippi, Sch Appl Sci, Dept Commun Sci & Disorders, University, MS 38677 USA
[3] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878551, Japan
来源：
PSYCHOPHARMACOLOGY | 2017年 / 234卷 / 23-24期
关键词：
COGNITIVE DEFICITS; DOUBLE-BLIND;
D O I：
10.1007/s00213-017-4757-8
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：3537 / 3538
页数：2
相关论文
共 50 条
  • [1] Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia
    Veerman, Selene
    Schulte, Peter
    de Haan, Lieuwe
    PSYCHOPHARMACOLOGY, 2017, 234 (23-24) : 3535 - 3536
  • [2] Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia
    Selene Veerman
    Peter Schulte
    Lieuwe de Haan
    Psychopharmacology, 2017, 234 : 3535 - 3536
  • [3] Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
    Kishi, Taro
    Matsuda, Yuki
    Iwata, Nakao
    PSYCHOPHARMACOLOGY, 2017, 234 (14) : 2113 - 2125
  • [4] Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
    Taro Kishi
    Yuki Matsuda
    Nakao Iwata
    Psychopharmacology, 2017, 234 : 2113 - 2125
  • [5] Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study
    Quattrone, D.
    Bruno, A.
    Mico, U.
    Pandolfo, G.
    Scimeca, G.
    Muscatello, M. R.
    Zoccali, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S469 - S469
  • [6] Improvement of Schizophrenia Negative and Positive Symptoms With Memantine as Add-On Therapy to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial
    de Lucena, David
    Fernandes, Brisa
    Berk, Michael
    Dood, Seetal
    Medeiros, Dalton W.
    Pedrini, Mariana
    Kunz, Mauricio
    Gomes, Fabiano
    Giglio, Larriany
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo
    Gama, Clarissa S.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 211S - 211S
  • [7] Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial
    Lucena, D.
    Fernandes, B.
    Berk, M.
    Dodd, S.
    Medeiros, D. W.
    Pedrini, M.
    Kunz, M.
    Gomes, F.
    Giglio, L.
    Lobato, M. I.
    Belmonte-de-Abreu, P.
    Gama, C. S.
    BIPOLAR DISORDERS, 2009, 11 : 57 - 57
  • [8] Combination of clozapine and escitalopram in treatment of negative symptoms in residual schizophrenia
    Zivkovic, N.
    Bajovic, B.
    Djokic, G.
    Pavicevic, D.
    Ilic, M.
    Tomic, M.
    Lekovic, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S473 - S473
  • [9] Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
    de Lucena, David
    Fernandes, Brisa Simoes
    Berk, Michael
    Dodd, Seetal
    Medeiros, Dalton W.
    Pedrini, Mariana
    Kunz, Mauricio
    Gomes, Fabiano Alves
    Giglio, Larriany F.
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo Silva
    Gama, Clarissa Severino
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (10) : 1416 - 1423
  • [10] Successful Use of Add-on Minocycline for Treatment of Persistent Negative Symptoms in Schizophrenia
    Jhamnani, Kapil
    Shivakumar, Venkataram
    Kalmady, Sunil
    Rao, Naren P.
    Venkatasubramanian, Ganesan
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (01) : E6 - E7
12345